BusinessUS FDA Issues Warning Letter to Aurobindo Pharma's Eugia Pharma Unit
The U.S. Food and Drug Administration has issued a warning letter to Eugia Pharma Specialities, a subsidiary of Aurobindo Pharma, concerning its formulation manufacturing facility near Hyderabad. The company stated it does not expect the action to affect current U.S. market supplies.
By Project Chintan Newsroom · 14 Aug
